Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer
Status:
Withdrawn
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The study goal is to develop a new method of intraoperative lymphatic mapping with
fluorescent contrast agents to improve the outcome of therapeutic breast cancer surgery.